BioNTech SE BNTX
NASDAQ BNTX
$97.15 -1.15 (-1.17%)
As of: Oct 1, 2026 · 2:56 PM EDT

BioNTech SE (BNTX) Gross Profit (2018 - 2026)

Updated

BioNTech SE's Gross Profit was $10 million in Q2 2026, down 95.2% from $208.73 million a year earlier and down 81.7% from the prior quarter.

Analysis

BioNTech SE (BNTX) Gross Profit (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioNTech SE's Gross Profit was $2.34 billion through Jun 30, 2026, down 6.4% year-over-year; for FY2025, it came in at $2.59 billion, up 9.8% from FY2024.

  • Gross Profit shows a five-year compound annual growth rate of 40.0% (FY2020 to FY2025).
  • In earlier years, Gross Profit was $2.36 billion in FY2024 (-31.8%), $3.46 billion in FY2023 (-76.3%), $14.61 billion in FY2022 (-20.5%) and $18.38 billion in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Gross Profit since Q2 2023.
  • Compared with a year earlier, Gross Profit has declined for three straight quarters, with growth averaging 4.4% over the last eight quarters.
  • The best year-over-year quarter for Gross Profit over five years was Q2 2025 (growth of 181.3%); the worst was Q2 2023 (a decline of 99.8%).
  • Per Business Quant data, BNTX's Gross Profit in the three quarters before Q2 2026 was $54.67 million (Q1 2026), $668.28 million (Q4 2025) and $1.6 billion (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

BioNTech SE Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=BNTX&period=max&api_key=YOUR_API_KEY